On Aug 9th, 2022, US Pacific Time, Technoderma Medicines (TDM), a drug discovery startup specialized in dermatology indications based at Jiaxing, China,announced that FDA approved the IND application of its novel experimental drug for the topical treatmen
Technoderma Medicines, Inc., a clinical stage biopharmaceutical company, is pleased to report the Company has begun dosing in its Phase 1b (MAD) clinical trial of topical TDM-105795 solution in patients with Androgenetic Alopecia (AGA).
On July 1, 2016, TechnoDerma announced the completion of a multi-million yuan Angel round of financing. The completion of financing marks the official launch of the startup company and its innovative small molecule drug discovery program for the treatment
